Regarding MYC, it is a key regulator of cell growth, proliferation, and apoptosis, and its dysregulation contributes to BC development and progression, resistance to adjuvant therapy, and it is also associated with poor outcomes [120]. This evidence concerns the gene MYC and breast cancer.